Mike Ruane
About Mike Ruane
Mike Ruane is the Director, Head of Site Quality Assurance at Bristol Myers Squibb in Warren, New Jersey, with extensive experience in quality assurance for cell therapy development and operations.
Title and Current Role
Mike Ruane is the Director, Head of Site Quality Assurance at Bristol Myers Squibb. He is based in Warren, New Jersey, United States, where he oversees the quality assurance strategies for the site.
Professional Experience at Bristol Myers Squibb
At Bristol Myers Squibb, Mike Ruane has held various significant roles. He served as the Site Head of Quality Assurance (ad interim) from 2021 to 2022, and as Associate Director, Quality Assurance Operations & Engineering from 2020 to 2021. In these roles, he managed site quality assurance operations, focusing on validating new biological targets and piloting new manufacturing technologies and testing methodologies.
Experience at Celgene
Mike Ruane held multiple roles at Celgene Corporation, culminating in the position of Senior Manager, Cell Therapy Development and Operations QA, from 2017 to 2020. He also served as Senior Manager and Manager in Commercial Quality Operations, and as an Associate Manager. His tenure at Celgene focused on ensuring the quality and safety of cell therapy products and commercial operations.
Career Beginnings and Early Roles
Mike Ruane began his career in the pharmaceutical sector at Abraxis BioScience where he served as Supervisor of QC Chemistry and Senior Chemist. Before that, he worked as an Associate Chemist at APP Pharmaceuticals and as a Field Engineer at Schlumberger. His early roles laid a strong foundation in quality control and chemical engineering.
Educational Background
Mike Ruane completed his MBA at DePaul University - Charles H. Kellstadt Graduate School of Business, specializing in Operations Management and Corporate Finance. He also holds a BS in Chemical Engineering from the University of Illinois Urbana-Champaign. These educational qualifications have equipped him with a strong technical and managerial foundation.
Significant Contributions at Bristol Myers Squibb
In his current role, Mike Ruane has led the implementation of phase-appropriate cGMPs for first-in-human trials at BMS's early phase cell therapy manufacturing site. He has also partnered with clinical manufacturing and QC teams to expedite the development of cell therapies and played a key role in ensuring the safety of investigational materials for trial subjects.